Securing the future of Cognitive Health Research with
COGNITION® International.
COGNITION® International, as the sole licensee of the COGNITION® Biobank, focuses on global research to prevent neurological conditions such as Alzheimer’s, dementia, ADHD, and autism. Impact investors have the opportunity to support this vital cause through investment in Redeemable Participating Preference (RPP) Shares, offering both social impact and financial returns. By contributing, investors help drive cutting-edge research on cognitive health while securing profitability by year three. Learn more about how you can be part of this transformative initiative.
